Regen BioPharma Inc (RGBP)

[OTCShotCaller]

Good Question!

Anyone's guess but I perceive IF a Buy Out-Merger Big Pharma Acquisition occurs RGBP stock holder's shares will be trading at the current PPS of the acquiring Company BUT with fewer shares. It depends on what the "per share" buy-out arrangements are.

It's important to keep in mind however that upon a Buy Out-Merger Acquisition the acquiring company will own ALL of RGBP's 20+ Patents Plus the current one that just got FDA approved to enter Clinical Trials. That by itself makes RGBP even more attractive as a Buy Out candidate for reason the acquiring company can immediately put that IND in its own clinical trials pipe line.

Due to its extensive portfolio of Disruptive Biotechnology Patents, the intrinsic valuation of RGBP is astonishing easily well into the Mega Multi-Billion Dollar range. The current Patent going to clinical trials soon has a global market capacity in the Multi-Billion dollar range by itself!

Therefore, the PPS buy out PER SHARE, again IF that occurs, could be in the dollar range with all things considered.

This of course is my personal opinion only.

Be well and prosper...